Astaxanthin (AstaReal) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial
Hecht KA, Marwah M, Wood V, Nishida Y, Bach AE, Gerson J, Hom MM, Schnackenberg J, Raote S, Srivastava S, Negi P, Caston E
Published in Advances in Therapy
Methodology
Randomized, double-blind, placebo-controlled 84-day trial of 4 mg/day astaxanthin in children aged 10-14 with computer vision syndrome
Key Findings
Astaxanthin improved Computer Vision Syndrome Questionnaire scores and visual fatigue measures versus placebo over 84 days, with no safety signals.
Conclusions
Astaxanthin improved acute and chronic digital eye strain symptoms in school-aged children.
Limitations
Single small trial funded and authored by the ingredient manufacturer; subjective primary endpoint; children only.
Supplements Studied
This study assessed the effects of astaxanthin supplementation on chronic and acute digital eye strain in school-aged children
Outcomes Measured
Astaxanthin (AstaReal) Improved Acute and Chronic Digital Eye Strain in Children
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
AstaReal (industry-sponsored; authors include company employees)
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.